Status:
COMPLETED
Trefoil Peptides in Lung Diseases
Lead Sponsor:
Bispebjerg Hospital
Conditions:
Chronic Obstructive Pulmonary Disease
Asthma
Eligibility:
All Genders
18+ years
Brief Summary
The study focuses on trefoil family factor (TFF) peptides in sputum in lung diseases. The investigators hypothesize that TFF peptides are upregulated in lung diseases characterized by mucus hypersecre...
Eligibility Criteria
Inclusion
- Age 18 years or older
- Informed consent
Exclusion
- Upper and lower airway infection 2 weeks prior to visit 1
Key Trial Info
Start Date :
February 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2010
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00839735
Start Date
February 1 2009
End Date
May 1 2010
Last Update
February 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Respiratory and Allergy Research Unit, Department of Respiratory Medicine L, Bispebjerg Hospital
Copenhagen, Denmark, 2400